Android port of Radamsa vs ImmuniWeb® MobileSuite: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros & cons — compared head-to-head.
Android port of Radamsa is a free penetration testing tool. ImmuniWeb® MobileSuite is a commercial penetration testing tool by ImmuniWeb. Compare features, ratings, integrations, and community reviews side by side to find the best penetration testing fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Mobile security teams testing native Android libraries and system components need Android port of Radamsa because it's one of the few fuzzers that generates valid mutation sequences across ARM and x86 ABIs without requiring app recompilation. The tool's 68 GitHub stars and zero-dependency native compilation via Android NDK make it fast to integrate into CI/CD pipelines for pre-release fuzzing of C/C++ code. Skip this if you're fuzzing Kotlin/Java app logic or need guided feedback-driven fuzzing; Radamsa is mutation-based and dumb, which is exactly why it finds edge cases that smarter fuzzers miss.
Development and security teams shipping native iOS and Android apps need ImmuniWeb® MobileSuite because its zero-false-positives SLA actually holds; you get manual penetration testing paired with AI automation, which means fewer alert binges and faster remediation cycles than pure-automation competitors. The vendor guarantees rapid delivery timelines and maintains NIST ID.RA risk assessment coverage, so you're not just scanning,you're getting structured evidence for compliance audits and board reporting. Skip this if your priority is backend infrastructure scanning alone; MobileSuite's strength is the mobile-first assessment, not API or cloud workload testing.
